Speakers from the world's largest organisations will share their needs & experiences with many world first announcements. Learn of the requirements and case studies from end users and hear all about the latest innovations from companies across the value chain. In total, hear insights from 250 speakers.
In this talk I will give an overview of our main considerations for choosing and deploying wearable technologies in clinical trials. As an example I will explain how we went about introducing a specific wearable in some of our ongoing studies, and the impact that this is expected to make in assessing treatment efficacy.
Speaker Biography (Matthew Heasley)
Matthew Heasley currently works on the implementation of patient centric sensing technologies in clinical studies for GSK. Prior to this role Matthew worked on a wide variety of research projects in GSK including novel methods for drug delivery, bioelectronics, diagnostics and novel instrumentation.
Matthew received a MEng in electronic engineering from the University of Cambridge.
Company Profile (GSK)
GSK is a British multinational science-led global healthcare company headquartered in Brentford, London. The company researches and develops a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare. GSK has a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.